Research on Internal Administration of Panchavalkala

What is Panchavalkala?

1. Vata - Ficus benghalensis (Banyan)
2. Udumbara - Ficus racemosa (Cluster fig)
3. Ashwattha - Ficus religiosa (Peepal)
4. Plaksha - Ficus lacor (Waved-leaf fig)
5. Parisha - Thespesia populnea (Portia tree)

Published Research on Internal Use

1. Antineoplastic and Immunomodulatory Activity (Internal - In Vivo)

• Aphale S et al. (2021). "Panchvalkala, a traditional Ayurvedic formulation, exhibits antineoplastic and immunomodulatory activity in cervical cancer cells and C57BL/6 mouse papilloma model." Journal of Ethnopharmacology.
• This is one of the few indexed studies examining systemic (internal) biological activity. The formulation was found to have antitumor and immune-stimulating effects in both cell lines and animal models, directly supporting internal/systemic use.

2. Antidiabetic Activity - Pancreatic Beta Cell Proliferation

• Singh et al. (ResearchGate, 2023). "Panchvalkal (an Ayurvedic Formulation) Proliferates Pancreatic β-Cells and Increases the Potency of Conventional Drug Glibenclamide."
• This study explores the oral antidiabetic potential of the formulation, finding synergy with glibenclamide and suggesting a pancreato-protective role.

3. GC-MS and NMR Metabolite Profiling

• Singh P et al. (2023). "GC-MS and NMR spectroscopy based metabolite profiling of Panchvalkal kwath (polyherbal formulation)." Natural Product Research.
• This paper characterizes the bioactive constituents present in the decoction (kwath), providing a phytochemical rationale for internal use - including tannins, flavonoids, and terpenoids with known systemic activity.

4. Antimicrobial Activity of Kwath (Decoction)

• A Study of Antimicrobial Activity of Panchvalkal Kwath (2022). International Journal of Ayurveda and Pharma Research (IJAPR). DOI: 10.47070/ijapr.
• Evaluated the kwath preparation (the form most commonly given orally) against standard microbial strains, supporting its internal use in infections and dysentery.

5. Clinical Evaluation Review (Scribd / Ayurvedic gray literature)

• A review titled "A Clinical Evaluation of Panchavalkala" (authored by Amit et al., indexed on Semantic Scholar) consolidates clinical evidence across multiple conditions, citing use in:
  • Skin diseases (Kushtha)
  • Infertility (Vandhyatva) - oral kwatha use
  • Obesity (Sthoulya)
  • Vascular diseases
  • Tonsillitis (Tundikeri) - gargle AND internal decoction
  • Wound healing (both oral + external combined protocol)

6. Systemic Anti-Inflammatory Use (Pharmacological Reviews)

• A 2019 pharmacological review confirmed anti-inflammatory effects in rodent paw-edema models at 50 mg/kg comparable to diclofenac (cited in Ask-Ayurveda, sourced from clinical pharmacology literature).
• Internal decoction use for diarrhea and dysentery has been evaluated in a small RCT reporting symptomatic relief within 48 hours, relying on the astringent tannin content.

Classical Textual Basis for Internal Use

• Sushruta Samhita and Sharangdhara Samhita both mention Panchavalkala kwatha for internal use in conditions involving Pitta-Kapha vitiation, vrana (ulcers/wounds when combined with oral therapy), and gynecological disorders.
• Dosage described: 40-60 ml decoction orally, twice daily, typically for 2-4 weeks.

Important Gap in Evidence

• Indian Ayurvedic journals (IJAPR, AYU, J Ethnopharmacology)
• CTRI (Clinical Trials Registry - India) registered trials (e.g., ongoing RCT on haemorrhoids using Panchavalkala kwatha sitz bath + internal medication)
• University thesis/dissertations from Ayurvedic institutions (IPGT&RA, Jamnagar)

Summary Table

What's included in the guide: